NCT07659782
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07659782
Title A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer (TARGET-D 202)
Acronym TARGET-D 202
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Verastem, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
START LA Los Angeles California 90025 United States Details
START New Jersey East Brunswick New Jersey 08816 United States Details
START Fort Worth Fort Worth Texas 76104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field